152 related articles for article (PubMed ID: 8973035)
1. A case of Sézary syndrome associated with cutaneous transformation.
Sakai H; Matsuo S; Matsumoto M; Iizuka H
J Dermatol; 1996 Oct; 23(10):697-702. PubMed ID: 8973035
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous IL-8 production by CD4(+), CD7(+) leukemia cells in erythrodermic Sézary syndrome.
Ogawa F; Shimizu K; Hamasakia Y; Tanaka Y; Katayama I; Yamada Y; Tomonaga M
Leuk Lymphoma; 2002 May; 43(5):1061-6. PubMed ID: 12148887
[TBL] [Abstract][Full Text] [Related]
4. Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8 T cells.
Tokura Y; Yagi H; Seo N; Takagi T; Takigawa M
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):946-54. PubMed ID: 11044831
[TBL] [Abstract][Full Text] [Related]
5. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
[TBL] [Abstract][Full Text] [Related]
6. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
[TBL] [Abstract][Full Text] [Related]
7. A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma.
Carrozza PM; Kempf W; Kazakov DV; Dummer R; Burg G
Br J Dermatol; 2002 Sep; 147(3):582-6. PubMed ID: 12207606
[TBL] [Abstract][Full Text] [Related]
8. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
9. Skin infiltration in acute promyelocytic leukemia.
Nagao K; Kikuchi A; Kawai Y; Kizaki M; Ikeda Y; Nishikawa T
Dermatology; 1997; 194(2):168-71. PubMed ID: 9094468
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma.
Serke S; van Lessen A; Hummel M; Szczepek A; Huhn D; Stein H
Cytometry; 2000 Jun; 42(3):180-7. PubMed ID: 10861691
[TBL] [Abstract][Full Text] [Related]
11. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.
Bekkenk MW; Vermeer MH; Jansen PM; van Marion AM; Canninga-van Dijk MR; Kluin PM; Geerts ML; Meijer CJ; Willemze R
Blood; 2003 Sep; 102(6):2213-9. PubMed ID: 12750155
[TBL] [Abstract][Full Text] [Related]
12. CD7-positive Sézary syndrome with a Th1 cytokine profile.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
[TBL] [Abstract][Full Text] [Related]
13. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
[TBL] [Abstract][Full Text] [Related]
14. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
Vonderheid EC; Bigler RD; Kotecha A; Boselli CM; Lessin SR; Bernengo MG; Polansky M
J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
[TBL] [Abstract][Full Text] [Related]
15. Large cell transformation of Sézary syndrome. A conventional and molecular cytogenetic study.
So CC; Wong KF; Siu LL; Kwong YL
Am J Clin Pathol; 2000 Jun; 113(6):792-7. PubMed ID: 10874879
[TBL] [Abstract][Full Text] [Related]
16. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
[TBL] [Abstract][Full Text] [Related]
17. Immunoelectron microscopy in mycosis fungoides and benign dermatoses. Expression of CD3, CD4 and CD7 receptors.
Grzanka AA; Placek W; Grzanka A; Sokolowska-Wojdylo M; Zuryn A
Neoplasma; 2010; 57(1):41-6. PubMed ID: 19895171
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death.
Rappl G; Abken H; Muche JM; Sterry W; Tilgen W; André S; Kaltner H; Ugurel S; Gabius HJ; Reinhold U
Leukemia; 2002 May; 16(5):840-5. PubMed ID: 11986945
[TBL] [Abstract][Full Text] [Related]
19. Corneal perforation due to limbal involvement in Sézary syndrome.
Livingstone I; Ramamurthi S; Drummond S; Kemp E; Roberts F
Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1091-4. PubMed ID: 21253759
[TBL] [Abstract][Full Text] [Related]
20. [CD8-positive, CD30-negative cutaneous T-cell lymphoma simulating pyoderma gangrenosum].
Dueck D; Hermes B; Audring H; Kohl PK
Hautarzt; 2002 Feb; 53(2):114-7. PubMed ID: 11963190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
